UI09RBM300CT

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameUI09RBM300CT
Drug Alias NameUI09RBM300CT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMucosal protective
TargetsUpdating
Therapy Area/IndicationsStomach Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKorea United Pharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKorea United Pharm Inc
Active IndicationsN/A
Inactive IndicationsStomach Ulcer

Other Information

ATC CodeN/A
Related LinksN/A